{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:13:58Z","timestamp":1715213638485},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,12,1]]},"DOI":"10.2169\/internalmedicine.7232-21","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T22:08:47Z","timestamp":1623449327000},"page":"3795-3799","source":"Crossref","is-referenced-by-count":2,"title":["High-grade Primary Central Nervous System Lymphomatoid Granulomatosis: Successful Rituximab Monotherapy"],"prefix":"10.2169","volume":"60","author":[{"given":"Sakiko","family":"Harada","sequence":"first","affiliation":[{"name":"Department of Hematology, Juntendo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University School of Medicine, Japan"},{"name":"Department of Transfusion Medicine and Stem Cell Regulation, Juntendo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Nitta","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadaaki","family":"Inano","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Hirasawa","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Juntendo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihide","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Juntendo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, Kurume University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Pittaluga SWW, Jaffe ES. Lymphomatoid granulomatosis. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised Fourth Edition. Swerdlow SH, Campo E, Harris NL, et al., Eds. IARC, Lyon, 2017: 312."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Liebow AA, Carrington CR, Friedman PJ. Lymphomatoid granulomatosis. Hum Pathol 3: 457-558, 1972.","DOI":"10.1016\/S0046-8177(72)80005-4"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Melani C, Jaffe ES, Wilson WH. Pathobiology and treatment of lymphomatoid granulomatosis, a rare EBV-driven disorder. Blood 135: 1344-1352, 2020.","DOI":"10.1182\/blood.2019000933"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Song JY, Pittaluga S, Dunleavy K, et al. Lymphomatoid granulomatosis--a single institute experience: pathologic findings and clinical correlations. Am J Surg Pathol 39: 141-156, 2015.","DOI":"10.1097\/PAS.0000000000000328"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Katzenstein AL, Carrington CB, Liebow AA. Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases. Cancer 43: 360-373, 1979.","DOI":"10.1002\/1097-0142(197901)43:1<360::AID-CNCR2820430151>3.0.CO;2-8"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Nishihara H, Tateishi U, Itoh T, Nagashima K, Tanaka S. Immunohistochemical and gene rearrangement studies of central nervous system lymphomatoid granulomatosis. Neuropathology 27: 413-418, 2007.","DOI":"10.1111\/j.1440-1789.2007.00804.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tanaka H, Furukawa S, Takeda Y, et al. Primary cerebral lymphomatoid granulomatosis progressing to methotrexate-associated lymphoproliferative disease under immunosuppressive therapy. Intern Med 54: 503-507, 2015.","DOI":"10.2169\/internalmedicine.54.2399"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lucantoni C, De Bonis P, Doglietto F, et al. Primary cerebral lymphomatoid granulomatosis: report of four cases and literature review. J Neurooncol 94: 235-242, 2009.","DOI":"10.1007\/s11060-009-9834-3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Dunleavy K, Roschewski M, Wilson WH. Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes. Curr Hematol Malig Rep 7: 208-215, 2012.","DOI":"10.1007\/s11899-012-0132-3"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Roschewski M, Wilson WH. Lymphomatoid granulomatosis. Cancer J 18: 469-474, 2012.","DOI":"10.1097\/PPO.0b013e31826c5e19"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Chavez JC, Sandoval-Sus J, Horna P, et al. Lymphomatoid granulomatosis: a single institution experience and review of the literature. Clin Lymphoma Myeloma Leuk 16 (Suppl): S170-S174, 2016.","DOI":"10.1016\/j.clml.2016.02.024"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Zaidi A, Kampalath B, Peltier WL, Vesole DH. Successful treatment of systemic and central nervous system lymphomatoid granulomatosis with rituximab. Leuk Lymphoma 45: 777-780, 2004.","DOI":"10.1080\/10428190310001625854"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ishiura H, Morikawa M, Hamada M, et al. Lymphomatoid granulomatosis involving central nervous system successfully treated with rituximab alone. Arch Neurol 65: 662-665, 2008.","DOI":"10.1001\/archneur.65.5.662"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Olmes DG, Agaimy A, Kloska S, Linker RA. Fatal lymphomatoid granulomatosis with primary CNS-involvement in an immunocompetent 80-year-old woman. BMJ Case Rep 2014: bcr2014206825, 2014.","DOI":"10.1136\/bcr-2014-206825"},{"key":"15","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1182\/blood-2002-06-1636","volume":"101","author":"JL Rubenstein","year":"2003","unstructured":"15. Rubenstein JL, Combs D, Rosenberg J, et al. Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood 101: 466-468, 2003.","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Singh PK, Pan E. Review of rituximab in primary CNS lymphoma. J Neurol Sci 410: 116649, 2020.","DOI":"10.1016\/j.jns.2019.116649"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Randall KL. Rituximab in autoimmune diseases. Aust Prescr 39: 131-134, 2016.","DOI":"10.18773\/austprescr.2016.053"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/23\/60_7232-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T04:42:21Z","timestamp":1715143341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/23\/60_7232-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":17,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7232-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,1]]},"article-number":"7232-21"}}